REGULATED PRESS RELEASE published on 11/18/2024 at 15:37, 2 days 19 hours ago Statement of transactions in own shares from November 11, 2024 to November 15, 2024
BRIEF published on 11/12/2024 at 12:04, 8 days 22 hours ago SAFRAN Updates on Share Capital and Voting Rights Safran Voting Rights French Commercial Code Shares AMF Regulations
REGULATED PRESS RELEASE published on 11/12/2024 at 11:59, 8 days 22 hours ago Statement about the number of shares composing the share capital and the number of voting rights as at October 31, 2024 Safran's monthly statement discloses total number of shares and voting rights according to French commercial code and AMF regulations Safran Share Capital Voting Rights French Commercial Code Monthly Statement
REGULATED PRESS RELEASE published on 11/04/2024 at 17:31, 16 days 17 hours ago Statement of transactions in own shares from October 28, 2024 to November 1, 2024
REGULATED PRESS RELEASE published on 10/28/2024 at 16:51, 23 days 18 hours ago Statement of transactions in own shares from October 21, 2024 to October 25, 2024
BRIEF published on 10/25/2024 at 07:05, 27 days 3 hours ago Safran Raises Full-Year Profit Outlook for 2024 Safran Revenue Growth 2024 Outlook Supply Chain Aftermarket Expansion
REGULATED PRESS RELEASE published on 10/25/2024 at 07:00, 27 days 3 hours ago Safran - Full-year outlook profit raised Safran reports a 14.0% increase in Q3 2024 revenue, raising full-year profit forecast. CEO optimistic about future growth. Updated FY 2024 outlook provided Safran Revenue Growth Q3 2024 Profit Forecast
REGULATED PRESS RELEASE published on 10/14/2024 at 14:50, 1 month 6 days ago Statement of transactions in own shares from October 07, 2024 to October11, 2024
BRIEF published on 10/11/2024 at 09:44, 1 month 10 days ago SAFRAN Releases Share Capital and Voting Rights Details for September 2024 Share Capital Voting Rights Treasury Shares AMF Regulations SAFRAN Shares
REGULATED PRESS RELEASE published on 10/11/2024 at 09:39, 1 month 10 days ago Statement about the number of shares composing the share capital and the number of voting rights as at September 30, 2024 Monthly statement on the number of shares and voting rights for Safran SA as of September 30, 2024, in accordance with French commercial code and AMF regulations Safran Voting Rights French Commercial Code Shares AMF Regulations
Published on 11/21/2024 at 10:03, 53 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 56 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 56 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 21 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 31 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 26 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 51 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 53 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 56 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 56 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 58 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 36 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo